Reviewed clinical summary · Source-linked · Educational use only

Can CBT for Diet Improve Glucose and Pregnancy Outcomes in Gestational Diabetes?

Clinical Bottom Line

A multicentre RCT finds a CBT-based dietary app improves postprandial glucose and reduces macrosomia in gestational diabetes. PICO summary and commentary.

Summary: In a multicentre trial in gestational diabetes, a CBT-based digital dietary intervention improved the glycaemic qualification rate, lowered post-lunch and post-dinner glucose, and reduced macrosomia compared with standard care, though fasting and post-breakfast glucose were unchanged.

PICO Summary

ElementDetail
Population200 women with gestational diabetes (171 completed); enrolled around 26 weeks; multicentre, China.
InterventionStandard care plus a CBT-based digital dietary programme (structured education and behavioural strategies via a WeChat mini program).
ComparisonStandard care alone.
OutcomeHigher glycaemic qualification rate at successive follow-ups (e.g. 87.9% vs 81.9%; p=0.02) and lower post-lunch and post-dinner glucose, with higher self-efficacy and lower macrosomia (5% vs 15%; p=0.04). No significant difference in fasting or post-breakfast glucose.
RCT J Med Internet Res · 2025

CBT dietary app in gestational diabetes

RCT · gestational diabetes · enrolment to delivery

Trial design
GDM, enrolled ~26 weeks Enrolled & assessed RANDOMISED 1:1 CBT dietary app Standard care + CBT app n = 100 Standard care Standard care alone n = 100 Glycaemic qualification rate
Proportion reaching endpoint
p=0.02 % glycaemic qualification (FU3) 87.9% CBT dietary app 81.9% Standard care ARR+6.0 pp
Glycaemic qualification (FU3)
87.9% vs 81.9%
p=0.02
Macrosomia
5% vs 15%
p=0.04
Post-lunch glucose (2h)
5.1 vs 5.3 mmol/L
p=0.03
Self-efficacy (GSES)
195.4 vs 192.9
higher
⬡ Bottom Line

A CBT-based dietary app raised the glycaemic qualification rate and cut macrosomia from 15% to 5%, but fasting and post-breakfast glucose were unchanged.

Expert Commentary

This is a sensible and clinically attractive trial, because the weak link in gestational diabetes management is rarely the dietary advice itself but adherence to it, and applying cognitive behavioural techniques to support that adherence is a logical move. The results are encouraging on the measures that matter: better glycaemic qualification, lower postprandial glucose after the two larger meals, and, most importantly, a meaningful reduction in macrosomia from 15% to 5%, a hard outcome with real consequences for mother and baby. I would keep two honest qualifiers in view. First, the benefit was selective, fasting and post-breakfast glucose did not differ, so this sharpened daytime postprandial control rather than transforming the whole profile. Second, it is a single-country, app-delivered intervention with about 15% attrition, and the macrosomia finding, while striking, comes from modest numbers. Can I use this with my patients? Yes, in principle. It supports pairing dietary instruction in gestational diabetes with structured behavioural support rather than information alone, and digital delivery makes that scalable, while I would temper expectations to postprandial control and await replication for the macrosomia benefit.

References

Pan Y, Tang J, Lu B, et al. Effects of cognitive behavioral therapy for diet on postprandial glucose and pregnancy outcomes in gestational diabetes mellitus: multicenter randomized controlled trial. J Med Internet Res. 2025;27:e71075. doi:10.2196/71075

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.